Toi Masakazu

トイマサカズ | Toi Masakazu

Affiliation and department：

Research field (1)： Tumor diagnostics and therapeutics

Research theme for competitive and other funds (19)：

2023 - 2028 SR-PETによる各種腫瘍のSSTR発現評価とPRRT適応可能性の検証
2019 - 2022 間質応答を利用したホルモン受容体陽性乳がんの治療戦略の構築
2018 - 2021 Development of breast cancer serum diagnostic method using NMR measurement based on a new concept
2016 - 2020 Development of advanced photoacoustic imaging system based on integration of optics and ultrasound and control of optical phase space
2016 - 2019 Epigenetic profiling of cfDNA in breast cancer samples

Show all

Papers (831)：

Akane Higami, Masahiro Takada, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Kosuke Kawaguchi, Ayane Yamaguchi, Yasuhide Takeuchi, Yosuke Yamada, Masakazu Toi. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients. International Journal of Clinical Oncology. 2024
Yurina Maeshima, Tatsuki R Kataoka, Alexis Vandenbon, Masahiro Hirata, Yasuhide Takeuchi, Yutaka Suzuki, Yukiko Fukui, Masahiro Kawashima, Masahiro Takada, Yumiko Ibi, et al. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals a reduction in CD169+ macrophages within metastatic breast cancers. EBioMedicine. 2024. 107. 105271-105271
Tomoko Izawa, Ami Kobayashi, Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Akiyoshi Nakakura, Yuki Kataoka, Kenichiro Shide, Yukiko Mori, Kazuhiro Yamazaki, Masakazu Toi, et al. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study. BMC women's health. 2024. 24. 1. 165-165
Eriko Tokunaga, Yasuo Miyoshi, Koji Dozono, Tsutomu Kawaguchi, Masakazu Toi. Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial. The oncologist. 2024. 29. 3. e319-e329
Masaya Hattori, Naoko Honma, Shigenori Nagai, Kazutaka Narui, Tomoko Shigechi, Yukinori Ozaki, Masayuki Yoshida, Takashi Sakatani, Eiichi Sasaki, Yuko Tanabe, et al. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines. Breast cancer (Tokyo, Japan). 2024

ｍore...

MISC (450)：

弓削瞬介, 三宅可奈江, 高田正泰, 志水陽一, 北野香雪, 片岡正子, 石守崇好, 川島雅央, 河口浩介, 戸井雅和, et al. 浸潤性小葉癌におけるF-18FES PETの有用性. 核医学(Web). 2023. 60. Supplement
三宅可奈江, 高田正泰, 志水陽一, 弓削瞬介, 北野香雪, 石守崇好, 片岡正子, 板垣孝治, 川島雅央, 戸井雅和, et al. De novo ER陽性乳癌における[F-18]-FES PETの診断能:全身PET/CTと乳房PET/MRの比較. 核医学(Web). 2023. 60. Supplement
橋本陽菜, 片岡正子, 藤本晃司, 藤本晃司, 飯間麻美, 飯間麻美, 戸井雅和, 川瀬貫互, 大橋茜, 大橋茜, et al. Quantification of Tumor-Related Vessel Length on UF-DCE MRI and Their Association with Breast Cancer Subtypes [Presidential Award Proceedings]. 日本磁気共鳴医学会雑誌(Web). 2023. 43. 2
弓削瞬介, 三宅可奈江, 片岡正子, 八上全弘, 磯田裕義, 石守崇好, 松本純明, 高田正泰, 戸井雅和, 中本裕士. 任意型検診における乳房専用PETの診断能-初診群と再診群による比較-. 核医学(Web). 2022. 59. Supplement
太田理恵, 片岡正子, 飯間麻美, 三宅可奈江, 大野文美, 本田茉也, 山田洋介, 竹内康英, 高田正泰, 戸井雅和, et al. 高解像度拡散強調画像とT1/T2強調画像を用いた非造影MRIによる乳房病変の診断アルゴリズム. 日本乳癌学会学術総会プログラム・抄録集. 2022. 30th (CD-ROM)

ｍore...

Lectures and oral presentations (1)：

Management of Residual Disease after Neo-adjuvant CT in Her2 neu positive Breast Cancer.
(2019)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page